Merck, one of America’s largest pharmaceutical companies, put in an emergency use authorization request for a pill that may be the first to treat COVID-19.
On Friday, the pharmaceutical company released a statement declaring that it was preparing to apply for emergency use of its molnupiravir tablet with the Food and Drug Administration. If approved by the FDA, the tablet would be the first oral antiviral medicine to be used to treat the coronavirus, Reuters reported.
Real journalism.Trusted by millions.
Unlimited access to in-depth reporting, expert analysis, and the stories that shape our country.
Subscribe Now
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.